✦ LIBER ✦
Standard-dose imatinib plus low-dose homoharringtonine and granulocyte colony-stimulating factor is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis who have failed prior single-agent therapy with imatinib
✍ Scribed by Baijun Fang; Ning Li; Yongping Song; Qin Han; Robert Chunhua Zhao
- Book ID
- 105989635
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 127 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.